FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0544 | 71283-0544-2 | Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 30 mg/1 mL; 1 mg/1 mL; 10 ug/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0550 | 71283-0550-2 | Phentolamine Mesylate; Alprostadil; Atropine Sulfate; Papaverine Hydrochloride | 2 mg/1 mL; 60 ug/1 mL; .15 mg/1 mL; 30 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0931 | 71283-0931-1 | Baclofen | 4000 ug/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0620 | 71283-0620-2 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 3 mg/1 mL; 3 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0621 | 71283-0621-5 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 4 mg/1 mL; 3 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0226 | 71283-0226-3 | Sodium Ascorbate; Ascorbic Acid | 250 mg/1 mL; 500 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0226 | 71283-0226-5 | Sodium Ascorbate; Ascorbic Acid | 250 mg/1 mL; 500 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0220 | 71283-0220-3 | Biotin | 10 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-1010 | 71283-1010-1 | Bupivacaine | 50 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0634 | 71283-0634-1 | Triamcinolone | 40 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0666 | 71283-0666-2 | Triamcinolone Acetonide | 40 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0633 | 71283-0633-1 | Triamcinolone Acetonide | 50 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0632 | 71283-0632-1 | Triamcinolone Acetonide; Bupivacaine Hydrochloride | 40 mg/1 mL; 5 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0628 | 71283-0628-2 | Triamcinolone Diacetate | 40 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0627 | 71283-0627-1 | Triamcinolone Diacetate | 40 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0224 | 71283-0224-3 | Zinc Chloride | 10 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0533 | 71283-0533-5 | "gonadotrophin, Chorionic" | 1000 U/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0210 | 71283-0210-3 | Cholecalciferol | 1000 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0251 | 71283-0251-3 | Cholecalciferol | 100000 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0420 | 71283-0420-1 | Clonidine Hydrochloride | 10 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0642 | 71283-0642-1 | Dexamethasone Sodium Phosphate | 24 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-1012 | 71283-1012-5 | Dimethyl Sulfoxide; Lidocaine Hydrochloride | 550 mg/1 mL; 5 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-1022 | 71283-1022-1 | Fentanyl Citrate | 10 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0335 | 71283-0335-3 | Folic Acid | 10 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0543 | 71283-0543-2 | Alprostadil | 80 ug/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0549 | 71283-0549-2 | Alprostadil; Papaverine Hydrochloride; Atropine Sulfate; Phentolamine Mesylate | 40 ug/1 mL; 25 mg/1 mL; .01 mg/1 mL; .5 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0546 | 71283-0546-2 | Alprostadil; Papaverine Hydrochloride; Phentolamine Mesylate | 40 ug/1 mL; 30 mg/1 mL; 2 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-1020 | 71283-1020-1 | Hydromorphone Hydrochloride | 100 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0339 | 71283-0339-3 | Hydroxocobalamin | 5 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0532 | 71283-0532-5 | Hydroxyprogesterone Caproate | 250 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-1011 | 71283-1011-5 | Lidocaine | 40 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0990 | 71283-0990-6 | Lidocaine Hydrochloride; Hyaluronic Acid | 10 mg/1 mL; 10 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0990 | 71283-0990-2 | Lidocaine Hydrochloride; Hyaluronic Acid | 10 mg/1 mL; 10 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceuticals(087792998)" | 71283-0225 | 71283-0225-5 | Magnesium Chloride | 200 mg/1 mL | 2020-1 | valid | 2026-11-12 | ||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride | 1 mg/1 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride | 5 mg/1 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 5 mg/1 mL; 1 mg/1 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Ondansetron Hydrochloride; Ketamine Hydrochloride; Midazolam | 2 mg; 25 mg; 3 mg | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Lidocaine Hydrochloride | 15 mg/1 mL; 10 mg/1 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Tropicamide | 25 mg/1 mL; 10 mg/1 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Tropicamide; Proparacaine Hydrochloride; Ketorolac Tromethamine | 25 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL; 5 mg/1 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Acetate | 10 mg/1 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Acetate; Moxifloxacin Hydrochloride | 10 mg/1 mL; 5 mg/1 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Acetate; Moxifloxacin Hydrochloride; Nepafenac | 10 mg/1 mL; 5 mg/1 mL; 1 mg/1 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Acetate; Moxifloxacin Hydrochloride; Nepafenac | 10 mg/1 mL; 5 mg/1 mL; 1 mg/1 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Acetate; Nepafenac | 10 mg/1 mL; 1 mg/1 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Bromfenac Sodium; Prednisolone Sodium Phosphate | .75 mg/1 mL; 10 mg/1 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Bromfenac Sodium; Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride | .75 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Bromfenac Sodium; Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride | .75 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Triamcinolone Acetonide; Moxifloxacin Hydrochloride | 15 mg/1 mL; 1 mg/1 mL | 2020-1 | source_no_ndc | 2026-11-12 |